Latest Regulatory News

Arizona Lithium advances its Prairie Project with a pioneering commercial development plan for lithium brine extraction, regulatory approvals, and a $1.3 million capital raise to fund initial production.

Tolu Minerals has raised A$27.25 million through a placement to fund extensive exploration and refurbish its Tolukuma Gold Mine in Papua New Guinea, signaling a strategic push towards early gold production.

Norwest Minerals Limited has launched a $4.85 million entitlement offer to fund an aggressive drilling campaign and mining option review at its Bulgera Gold project, aiming to significantly expand its gold resource amid soaring gold prices.

Alligator Energy Limited has made significant strides in its uranium exploration and development projects, securing critical regulatory approvals and advancing field operations while maintaining a robust cash position. The company’s strategic investments and ongoing drilling programs position it well amid a strengthening uranium market.

Askari Metals has acquired 100% ownership of Rift Valley Metals, gaining a highly prospective 460 km² gold project portfolio in Ethiopia’s underexplored Adola Greenstone Belt. This move positions the company at the forefront of exploration in a prolific gold region with significant discovery potential.

Little Green Pharma reported a robust 40% revenue increase for FY25, driven by strong European sales and the strategic acquisition of Health House. The company also advanced clinical research and secured new therapy funding, positioning itself for continued growth.

Boab Metals has inked a A$10 million deal to acquire the DeGrussa Processing Plant from Sandfire Resources, significantly derisking and reducing upfront capital costs for its Sorby Hills Project. Completion hinges on a final investment decision expected in the second half of 2025.

Tissue Repair Limited reports progress in its Phase 3 clinical trials for TR987® despite enrollment delays caused by US regulatory disruptions, while TR Pro+® sales hit record highs and manufacturing scale-up advances.

Argent BioPharma reports significant operational savings through manufacturing outsourcing, encouraging Phase IIb results for CimetrA®, and key regulatory approvals for cannabinoid therapies in Germany.

EV Resources Limited advances its position in the critical antimony market with a 70% stake acquisition in Mexico’s Los Lirios project and full ownership of Utah’s historic Coyote Creek claims, setting the stage for exploration and development.

Golden Mile Resources is set to commence its maiden drilling program at the Pearl Copper Project in Arizona, following significant gold and silver assays at the newly identified Aurora Prospect. The company has secured key federal permits, marking a pivotal step in its US exploration campaign.

Starpharma reports steady progress in its DEP® drug development programs, launches new marketing campaigns in key regions, and maintains a strong cash position of $17.2 million as it refines clinical strategies and partnerships.